Innovent Announces NMPA Approval Of Limertinib, A Third-Generation EGFR TKI Collaborated With ASK Pharma, For The First-Line Treatment Of Lung Cancer
(MENAFN – PR Newswire)SAN FRANCISCO and SUZHOU,China, April 25, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, …
